BranchLab, a New York-based data science company developing advanced AI software that enables healthcare brands to reach the right consumers, closed a seed funding round.  

Investors 

The round was led by Newark venture partners (nvp), with participation from Aperiam and several other strategic investors.  

Founded in 2015, newark venture partners (nvp) is a seed-stage, globally investing venture capital firm that backs bold founders building the next generation of enterprise software.  

BranchLab Use of Funds 

The company will use the funding to accelerate product development and market expansion for its privacy-safe healthcare advertising solutions for TV.   

About BranchLab 

Founded by Josh Walsh, Michael Parkes, and Chris Cagle, BranchLab provides a new solution for healthcare and pharma brands to reach consumers in a privacy-compliant way. Its database, HealthGraph™, aggregates anonymized data from over 300 million US residents and their healthcare journeys, including data on 2.1 million healthcare providers. BranchLab operates in the U.S. and is based in New York with offices in Colorado and Pennsylvania.  

Funding Details                                                  

Company: BranchLab, Inc.  

Raised: Undisclosed                                            

Round: Seed Round      

Funding Month: June 2024                            

Lead Investors: newark venture partners  

Additional Investors: Aperiam  

Company Website: https://branchlab.com/   

Software Category: Data Solutions  

Source: https://www.businesswire.com/news/home/20240606132070/en/